Literature DB >> 30929303

Expanding the Donor Pool With the Use of Extended Criteria Donation After Circulatory Death Livers.

Plamen Mihaylov1, Richard Mangus1, Burcin Ekser1, Arianna Cabrales2, Lava Timsina2, Jonathan Fridell1, Marco Lacerda3, Marwan Ghabril3, Lauren Nephew3, Naga Chalasani3, Chandrashekhar A Kubal1.   

Abstract

Use of donation after circulatory death (DCD) donor livers for transplantation has remained cautious in the United States. The aim of this study was to demonstrate the expansion of a DCD liver transplantation (LT) program with the use of extended criteria donor (ECD) DCD livers. After institutional review board approval, 135 consecutive DCD LTs were retrospectively studied. ECD DCD livers were defined as those with 1 of the following factors: donor age >50 years, donor body mass index >35 kg/m2 , donor functional warm ischemia time >30 minutes, and donor liver macrosteatosis >30%. An optimization protocol was introduced in July 2011 to improve outcomes of DCD LT, which included thrombolytic donor flush and efforts to minimize ischemia times. The impact of this protocol on outcomes was evaluated in terms of graft loss, ischemic cholangiopathy (IC), and change in DCD LT volume. Of 135 consecutive DCD LTs, 62 were ECD DCDs. In total, 24 ECD DCD LTs were performed before (era 1) and 38 after the institution of optimization protocol (era 2), accounting for an increase in the use of ECD DCD livers from 39% to 52%. Overall outcomes of ECD DCD LT improved in era 2, with a significantly lower incidence of IC (5% versus 17% in era 1; P = 0.03) and better 1-year graft survival (93% versus 75% in era 1; P = 0.07). Survival outcomes for ECD DCD LT in era 2 were comparable to matched deceased donor LT. With the expansion of the DCD donor pool, the number of DCD LTs performed at our center gradually increased in era 2 to account for >20% of the center's LT volume. In conclusion, with the optimization of perioperative conditions, ECD DCD livers can be successfully transplanted to expand the donor pool for LT.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 30929303     DOI: 10.1002/lt.25462

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  12 in total

1.  Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come.

Authors:  Omar Haque; Qing Yuan; Korkut Uygun; James F Markmann
Journal:  Clin Transplant       Date:  2021-01-21       Impact factor: 2.863

2.  Utilization of dielectric properties for assessment of liver ischemia-reperfusion injury in vivo and during machine perfusion.

Authors:  Jie Hou; Olav Magnus Ivar Liavåg; Ida Høy Færden; Ørjan Grøttem Martinsen; Tor Inge Tønnessen; Pål-Dag Line; Morten Hagness; Jan Olav Høgetveit; Søren Erik Pischke; Runar Strand-Amundsen
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.

Authors:  Stephanie Ohara; Elizabeth Macdonough; Lena Egbert; Abigail Brooks; Blanca Lizaola-Mayo; Amit K Mathur; Bashar Aqel; Kunam S Reddy; Caroline C Jadlowiec
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

Review 4.  The Changing Landscapes in DCD Liver Transplantation.

Authors:  Kristopher P Croome; C Burcin Taner
Journal:  Curr Transplant Rep       Date:  2020-07-13

5.  The volume-outcomes relationship in donation after circulatory death liver transplantation.

Authors:  Aaron M Delman; Kevin M Turner; Allison M Ammann; Emily Schepers; Dennis M Vaysburg; Alex R Cortez; Robert M Van Haren; Greg C Wilson; Shimul A Shah; Ralph C Quillin
Journal:  Clin Transplant       Date:  2022-04-25       Impact factor: 3.456

Review 6.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters.

Authors:  Naeem Goussous; Josue Alvarez-Casas; Noor Dawany; Wen Xie; Saad Malik; Stephen H Gray; Rolf N Barth; John C LaMattina
Journal:  Transplant Direct       Date:  2021-12-23

8.  Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain.

Authors:  Daiki Soma; Yujin Park; Plamen Mihaylov; Burcin Ekser; Marwan Ghabril; Marco Lacerda; Naga Chalasani; Richard S Mangus; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2022-01-05

Review 9.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

10.  Impact of Recipient Age in Combined Liver-Kidney Transplantation: Caution Is Needed for Patients ≥70 Years.

Authors:  Burcin Ekser; William C Goggins; Jonathan A Fridell; Plamen Mihaylov; Richard S Mangus; Andrew J Lutz; Daiki Soma; Marwan S Ghabril; Marco A Lacerda; John A Powelson; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.